PharmaEssentia Corporation Stock LUXEMBOURG S.E.
Stocks
261280523
US7169722037
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
2026-10-27
|
5-day change | 1st Jan Change | ||
| 36.80 USD | +3.37% |
|
+3.95% | +172.32% |
| Market Cap | 497B 15.33B 13.75B 12.71B 11.51B 21.51B 1,460B 21.77B 152B 60.54B 764B 57.51B 56.3B 2,425B | P/E 2026 * |
45.5x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 474B 14.62B 13.11B 12.12B 10.98B 20.51B 1,392B 20.76B 145B 57.74B 728B 54.85B 53.69B 2,312B | EV / Sales 2026 * |
17.5x | EV / Sales 2027 * | 11.2x |
| Free-Float |
79.23% | Yield 2026 * |
0.33% | Yield 2027 * | 0.2% |
| 1 day | +3.37% | ||
| 1 week | +3.95% | ||
| Current month | -3.66% | ||
| 1 month | +1.10% | ||
| 3 months | -0.54% | ||
| 6 months | +111.65% | ||
| Current year | +172.32% |
| 1 week | 35.6 |  | 36.8 |
| 1 month | 35.4 | | 38.4 |
| Current year | 14.05 | | 49.8 |
| 1 year | 13.06 | | 49.8 |
| 3 years | 8.65 | | 49.8 |
| 5 years | 7.97 | | 49.8 |
| 10 years | 7.97 | | 49.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 2016-12-31 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 2015-10-13 |
Cheng Ku Huang
PSD | President | - | 2015-06-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeffrey Williams
BRD | Director/Board Member | 73 | 2024-04-30 |
Shen Yi Li
BRD | Director/Board Member | - | 2021-08-04 |
Ching Tsun Liu
BRD | Director/Board Member | - | 2024-05-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.37% | +3.95% | - | - | 15.21B | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | |
| -0.94% | +0.77% | +8.85% | +100.19% | 53.59B | |
| +2.76% | +0.87% | +27.92% | +57.51% | 44.75B | |
| +2.00% | -3.39% | +17.83% | +100.08% | 41.62B | |
| +1.34% | -2.86% | +224.43% | +928.45% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +48.65% | +106.84% | +92.73% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.42% | -0.42% | +51.94% | +162.58% | 42.27B | |
| Weighted average by Cap. | +3.22% | -0.29% | +47.35% | +161.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 27.07B 834M 748M 692M 627M 1.17B 79.46B 1.19B 8.27B 3.3B 41.58B 3.13B 3.06B 132B | 41.5B 1.28B 1.15B 1.06B 961M 1.8B 122B 1.82B 12.68B 5.05B 63.74B 4.8B 4.7B 202B |
| Net income | 10.52B 324M 291M 269M 244M 455M 30.89B 461M 3.22B 1.28B 16.16B 1.22B 1.19B 51.31B | 17.96B 554M 497M 459M 416M 777M 52.72B 786M 5.49B 2.19B 27.59B 2.08B 2.03B 87.58B |
| Net Debt | -23.05B -710M -637M -589M -534M -997M -67.65B -1.01B -7.04B -2.81B -35.4B -2.67B -2.61B -112B | -34.24B -1.06B -947M -875M -793M -1.48B -101B -1.5B -10.47B -4.17B -52.59B -3.96B -3.88B -167B |
| Date | Price | Change |
|---|---|---|
| 26-10-27 | $36.80 | +3.37% |
| 26-10-22 | $35.60 | -1.66% |
| 26-10-21 | $36.20 | +2.26% |
| 26-10-20 | $35.40 | -2.21% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
- 261280523 Stock
Select your edition
All financial news and data tailored to specific country editions
